Geron Stock Analysis
| GERN Stock | USD 1.63 0.02 1.24% |
Geron holds a debt-to-equity ratio of 0.389. With a high degree of financial leverage come high-interest payments, which usually reduce Geron's Earnings Per Share (EPS).
Asset vs Debt
Equity vs Debt
Geron's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Geron's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Geron Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Geron's stakeholders.
For many companies, including Geron, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Geron, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Geron's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that Geron's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Geron is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Geron to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Geron is said to be less leveraged. If creditors hold a majority of Geron's assets, the Company is said to be highly leveraged.
Geron is undervalued with Real Value of 2.11 and Hype Value of 1.66. The main objective of Geron stock analysis is to determine its intrinsic value, which is an estimate of what Geron is worth, separate from its market price. There are two main types of Geron's stock analysis: fundamental analysis and technical analysis.
The Geron stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Geron is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day ( substitute day ), Independence Day. Geron Stock trading window is adjusted to America/New York timezone.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Geron. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. Geron Stock Analysis Notes
About 81.0% of the company shares are owned by institutional investors. The book value of Geron was currently reported as 0.39. The company recorded a loss per share of 0.12. Geron had not issued any dividends in recent years. The entity had 1058:1000 split on the 22nd of July 2014. Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. The company was incorporated in 1990 and is headquartered in Foster City, California. Geron Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 69 people. To learn more about Geron call Harout Semerjian at 650 473 7700 or check out https://www.geron.com.Geron Investment Alerts
| Geron may become a speculative penny stock | |
| Geron appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 76.99 M. Net Loss for the year was (174.57 M) with profit before overhead, payroll, taxes, and interest of 97.86 M. | |
| Geron currently holds about 219.29 M in cash with (218.62 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.58. | |
| Geron has a poor financial position based on the latest SEC disclosures | |
| Over 81.0% of the company shares are owned by institutional investors |
Geron Thematic Classifications
In addition to having Geron stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | Cancer FightersPublic companies from health care and pharmaceutical sectors that are focused on fighting cancer |
Geron Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.03 B.Geron Profitablity
The company has Profit Margin (PM) of (0.44) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.29) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.29.Technical Drivers
As of the 12th of February 2026, Geron retains the Risk Adjusted Performance of 0.169, downside deviation of 2.89, and Market Risk Adjusted Performance of 0.4863. Geron technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.Geron Price Movement Analysis
Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Weighted Moving Average calculates a weight for each value in Geron price series with the more recent values given greater weights.
Geron Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Geron insiders, such as employees or executives, is commonly permitted as long as it does not rely on Geron's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Geron insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Geron Outstanding Bonds
Geron issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Geron uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Geron bonds can be classified according to their maturity, which is the date when Geron has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Geron Predictive Daily Indicators
Geron intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Geron stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 600518.0 | |||
| Daily Balance Of Power | 0.2 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 1.6 | |||
| Day Typical Price | 1.61 | |||
| Price Action Indicator | 0.04 | |||
| Period Momentum Indicator | 0.02 |
Geron Forecast Models
Geron's time-series forecasting models are one of many Geron's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Geron's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Geron Bond Ratings
Geron financial ratings play a critical role in determining how much Geron have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Geron's borrowing costs.| Piotroski F Score | 4 | Poor | View |
| Beneish M Score | (2.15) | Possible Manipulator | View |
Geron Debt to Cash Allocation
As Geron follows its natural business cycle, the capital allocation decisions will not magically go away. Geron's decision-makers have to determine if most of the cash flows will be poured back into or reinvested in the business, reserved for other projects beyond operational needs, or paid back to stakeholders and investors.
Geron currently holds 121.72 M in liabilities with Debt to Equity (D/E) ratio of 0.39, which is about average as compared to similar companies. Geron has a current ratio of 4.75, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Geron's use of debt, we should always consider it together with its cash and equity.Geron Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Geron's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Geron, which in turn will lower the firm's financial flexibility.Geron Corporate Bonds Issued
About Geron Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Geron prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Geron shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Geron. By using and applying Geron Stock analysis, traders can create a robust methodology for identifying Geron entry and exit points for their positions.
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. The company was incorporated in 1990 and is headquartered in Foster City, California. Geron Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 69 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Geron to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Anywhere Now
Portfolio AnywhereTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Geron. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Will Biotechnology sector continue expanding? Could Geron diversify its offerings? Factors like these will boost the valuation of Geron. Market participants price Geron higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Geron data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Geron requires distinguishing between market price and book value, where the latter reflects Geron's accounting equity. The concept of intrinsic value - what Geron's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Geron's price substantially above or below its fundamental value.
Please note, there is a significant difference between Geron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Geron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Geron's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.